Catch-up growth in patients with congenital or acquired growth hormone deficiency after GH replacement: Clinical features and hypothalamic-pituitary imaging

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCARVALHO, L. R.
dc.contributor.authorARNHOLD, I. J. P.
dc.contributor.authorMENDONCA, B. B.
dc.contributor.authorCOSTALONGA, E. F.
dc.contributor.authorOTTO, A. P.
dc.contributor.authorLEITE, C. Da Costa
dc.contributor.authorLUCATO, L. T.
dc.contributor.authorPERUCHI, M. M.
dc.date.accessioned2023-02-09T19:56:13Z
dc.date.available2023-02-09T19:56:13Z
dc.date.issued2012
dc.description.abstractHypothalamic and pituitary disorders usually impair statural growth. These disorders may be either congenital or acquired with differences in clinical presentation. Growth failure is mainly related to growth hormone deficiency (GHD) that can be accompanied by other pituitary hormone deficiencies. The onset of clinical features may be insidious and unnoticed for years or decades. Therefore, it is important to periodically assess auxologic data such as height, growth velocity, bone maturation and evaluate hormonal levels related to hypothalamic-pituitary axis in these patients. Magnetic resonance imaging (MRI) greatly improved the study of central nervous system (CNS) disorders including the hypothalamic-pituitary region. Currently, it is an essential tool in the definition of the etiology of GHD. It can detect tumors that may require surgical intervention, and also provide insights into other causes of GHD. Catch up growth of congenital disorders is essentially dependent on hormone replacement. Even with an initial diagnosis of IGHD, attention should be given to the risk of the development of multiple pituitary hormone deficiencies. In addition to the hormonal deficiencies due to the acquired disorder themselves; their treatment (surgery, irradiation, chemotherapy) often leads to combined pituitary deficits. Growth responsiveness to rhGH has safety aspects of treatment which deserve additional discussion. © Springer Science+Business Media, LLC 2012. All rights reserved.
dc.identifier.citationCarvalho, L. R.; Arnhold, I. J. P.; Mendonca, B. B.; Costalonga, E. F.; Otto, A. P.; Da Costa Leite, C.; Lucato, L. T.; Peruchi, M. M.. Catch-up growth in patients with congenital or acquired growth hormone deficiency after GH replacement: Clinical features and hypothalamic-pituitary imaging. In: . HANDBOOK OF GROWTH AND GROWTH MONITORING IN HEALTH AND DISEASE: SPRINGER NEW YORK, 2012. p.963-985.
dc.identifier.doi10.1007/978-1-4419-1795-9_57
dc.identifier.isbn9781441917959; 9781441917942
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/51062
dc.language.isoeng
dc.publisherSPRINGER NEW YORK
dc.relation.ispartofHANDBOOK OF GROWTH AND GROWTH MONITORING IN HEALTH AND DISEASE
dc.rightsrestrictedAccess
dc.rights.holderCopyright SPRINGER NEW YORK
dc.titleCatch-up growth in patients with congenital or acquired growth hormone deficiency after GH replacement: Clinical features and hypothalamic-pituitary imaging
dc.typebookPart
dc.type.categorybook chapter
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalPERUCHI, M. M.:Division of Endocrinology, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcLUCIANI RENATA SILVEIRA DE CARVALHO
hcfmusp.contributor.author-fmusphcIVO JORGE PRADO ARNHOLD
hcfmusp.contributor.author-fmusphcBERENICE BILHARINHO DE MENDONCA
hcfmusp.contributor.author-fmusphcEVERLAYNY FIOROT COSTALONGA
hcfmusp.contributor.author-fmusphcALINE PEDROSA OTTO
hcfmusp.contributor.author-fmusphcCLAUDIA DA COSTA LEITE
hcfmusp.contributor.author-fmusphcLEANDRO TAVARES LUCATO
hcfmusp.description.beginpage963
hcfmusp.description.endpage985
hcfmusp.origemSCOPUS
hcfmusp.origem.scopus2-s2.0-85025613640
hcfmusp.relation.referenceAbdel Razek, A.A.K., Kandell, A.Y., Elsorogy, L.G., Elmongy, A., Basett, A.A., Disorders of cortical formation: MR imaging features (2009) AJNR, 30, pp. 4-11
hcfmusp.relation.referenceAcerini, C.L., Tasker, R.C., Traumatic brain injury induced hypothalamic-pituitary dysfunction: a paediatric perspective Pituitary (2007) Pituitary, 10, pp. 373-380
hcfmusp.relation.referenceArgyropoulou, M.I., Kiortsis, D., MRI of the hypothalamic-pituitary axis in children (2005) Pediatr Radiol, 35, pp. 1045-1055
hcfmusp.relation.referenceBarkovich, A.J., Fram, E.K., Normand, D., Septo-optic dysplasia: MR imaging (1989) Radiology, 171, pp. 189-192
hcfmusp.relation.referenceBihan, H., Christozova, V., Dumas, J.L., Jomaa, R., Valeyre, D., Tazi, A., Reach, G., Cohen, R., Sarcoidosis:clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature (2007) Medicine (Baltimore), 86, pp. 259-268
hcfmusp.relation.referenceBlethen, S.L., Baptista, J., Kuntze, J., Foley, T., Lafranchi, S., Johanson, A., Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group (1997) J Clin Endocrinol Metab, 82, pp. 418-420
hcfmusp.relation.referenceBonneville, F., Cattin, F., Marsot-Dupuch, K., Dormond, D., Bonneville, J.F., Chiras, J., T1 signal hyperintensity in the sellar region: spectrum of findings (2006) Radiographics, 26, pp. 93-113
hcfmusp.relation.referenceBucher, H., Zapf, J., Torresani, T., Prader, A., Froesch, E.R., Illig, R., Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma (1983) N Engl J Med, 309, pp. 1142-1146
hcfmusp.relation.referenceByrd, S., Magnetic resonance imaging of supratentorial congenital brain malformations (1989) J Natl Med Assoc, 81, pp. 873-881
hcfmusp.relation.referenceCaldarelli, M., Di Ricco, C., Diagnosis of Chiari I malformation and related syringomyelia: radiological and neurophysiological studies (2004) Childs Nerv Syst, 20, pp. 332-335
hcfmusp.relation.referenceCannavo, S., Venturino, M., Curto, L., De Menis, D., D'arrigo, C., Tita, P., Billleci, D., Trimarchi, F., Clinical presentation and outcome of pituitary adenomas in teenagers (2003) Clin Endocrinol (Oxf), 58, pp. 519-527
hcfmusp.relation.referenceChen, S., Leger, J., Garel, C., Hassan, M., Czernichow, P., Growth hormone deficiency with ectopic neurohypophysis:anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function (1999) J Clin Endocrinol Metab, 84, pp. 2408-2413
hcfmusp.relation.referenceCole, T.J., Hindmarsh, P.C., Dunger, D.B., Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency (2004) Arch Dis Child, 89, pp. 1024-1027
hcfmusp.relation.referenceCostalonga, E.F., Antonini, S.R., Guerra-Junior, G., Mendonca, B.B., Arnhold, I.J., Jorge, A.A., The-202 A allele of insulinlike growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency (2009) J Clin Endocrinol Metab, 94, pp. 588-595
hcfmusp.relation.referenceCostalonga, E.F., Jorge, A.A., Mendonca, B.B., Arnhold, I.J., [Mathematical models for predicting growth responses to growth hormone replacement therapy] (2008) Arq Bras Endocrinol Metabol, 52, pp. 839-849
hcfmusp.relation.referenceCottier, J.P., Destrieux, C., Brunereau, L., Bertrand, L., Bertrand, P., Moreau, L., Jan, M., Herbreteau, D., Cavernous sinus invasion by pituitary adenoma: MR imaging (2000) Radiology, 215, pp. 463-469
hcfmusp.relation.referenceCoutant, R., Rouleau, S., Despert, F., Magontier, N., Loisel, D., Limal, J.M., Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings (2001) J Clin Endocrinol Metab, 86, pp. 4649-4654
hcfmusp.relation.referenceCutfield, W., Lindberg, A., Albertsson Wikland, K., Chatelain, P., Ranke, M.B., Wilton, P., Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board (1999) Acta Paediatr Suppl, 88, pp. 72-75
hcfmusp.relation.referenceDarzy, K.H., Shalet, S.M., Hypopituitarism as a consequence of brain tumours and radiotherapy (2005) Pituitary, 8, pp. 203-211
hcfmusp.relation.referencede Boer, H., van der Veen, E.A., Why retest young adults with childhood-onset growth hormone deficiency? (1997) J Clin Endocrinol Metab, 82, pp. 2032-2036
hcfmusp.relation.referencede Ridder, M.A., Stijnen, T., Hokken-Koelega, A.C., Prediction of adult height in growth-hormone-treated children with growth hormone deficiency (2007) J Clin Endocrinol Metab, 92, pp. 925-931
hcfmusp.relation.referenceDelman, B.N., Fatterpekar, G.M., Law, M., Naidich, T.P., Neuroimaging for the pediatric endocrinologist (2008) Pediatr Endocrinol Rev, 5, pp. 708-719
hcfmusp.relation.referenceDutta, P., Bhansali, A., Singh, P., Bhat, M.H., Suprasellar tubercular abscess presenting as panhypopituitarism: a common lesion in an uncommon site with a brief review of literature (2006) Pituitary, 9, pp. 73-77
hcfmusp.relation.referenceFreeman, J.L., Zacharin, M., Rosenfeld, J.V., Harvey, A.S., The endocrinology of hypothalamic hamartoma surgery for intractable epilepsy (2003) Epileptic Disord, 5, pp. 239-247
hcfmusp.relation.referenceFrindik, J.P., Pituitary morphologic anomalies and magnetic resonance imaging in pediatric growth hormone deficiency (2001) Endocrinologist, 11 (4), pp. 289-295
hcfmusp.relation.referenceFrisch, H., Birnbacher, R., Final height and pubertal development in children with growth hormone deficiency after long-term treatment (1995) Horm Res, 43, pp. 132-134
hcfmusp.relation.referenceGabriel Zada, B.D., Mcnatt, S.A., Gordon Mccomb, J., Krieger, M.D., Surgical treatment of rathke cleft cysts in children (2009) Neurosurgery, 64, pp. 1132-1138
hcfmusp.relation.referenceGarcia-Filion, P., Epport, K., Nelson, M., Azen, C., Geffner, M.E., Fink, C., Borchert, M., Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective study (2008) Pediatrics, 121, pp. e653-e659
hcfmusp.relation.referenceConsensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society (2000) J Clin Endocrinol Metab, 85, pp. 3990-3993
hcfmusp.relation.referenceGottschling, S., Graf, N., Meyer, S., Reinhard, H., Krenn, T., Rohrer, T., Intracranial germinoma: a rare but important differential diagnosis in children with growth retardation (2006) Acta Paediatr, 95, pp. 302-305
hcfmusp.relation.referenceGuyda, H.J., Four decades of growth hormone therapy for short children: what have we achieved? (1999) J Clin Endocrinol Metab, 84, pp. 4307-4316
hcfmusp.relation.referenceJohnsen, D.E., Woodruff, W.W., Allen, I.S., Cera, P.J., Funkhouser, G.R., Colemn, L.L., MR imaging of the sellar and juxtasellar regions (1991) Radiographics, 11, pp. 727-758
hcfmusp.relation.referenceJorge, A.A., Arnhold, I.J., Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment (2009) Horm Res, 71, pp. 55-63
hcfmusp.relation.referenceJostel, A.S., Shallet, S.M., (2007) Growth hormone therapy in pediatrics-20 years of KIGS, pp. 240-249. , Ranke MB, Price DA, Reiter EO, editors, Childhood brain tumours and growth hormone treatment. Basel, Karger
hcfmusp.relation.referenceJung, H., Neumaier Probst, E., Hauffa, B.P., Partsch, C.J., Dammann, O., Association of morphological characteristics with precocious puberty and/or gelastic seizures in hypothalamic hamartoma (2003) J Clin Endocrinol Metab, 88, pp. 4590-4595
hcfmusp.relation.referenceKaravitaki, N., Cudlip, S., Adams, C.B., Wass, J.A., Craniopharyngiomas (2006) Endocr Rev, 27, pp. 371-397
hcfmusp.relation.referenceKaravitaki, N., Warner, J.T., Marland, A., Shine, B., Ryan, F., Arnold, J., Turner, H.E., Wass, J.A., GH replacement does not increase the risk of recurrence in patients with craniopharyngioma (2006) Clin Endocrinol (Oxf), 64, pp. 556-560
hcfmusp.relation.referenceKristrom, B., Wikland, K.A., Growth prediction models, concept and use (2002) Horm Res, 57, pp. 66-70
hcfmusp.relation.referenceKucharczyk, W., Bishop, J.E., Plewes, D.B., Keller, M.A., George, S., Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging (1994) AJR, 163, pp. 671-679
hcfmusp.relation.referenceKunii, N., Abe, T., Kawako, M., Tanioka, D., Izumiyama, H., Moritani, T., Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging (2007) Acta Neurochir (wien), 149, pp. 759-769
hcfmusp.relation.referenceLam, K.S., Sham, M.M., Tam, S.C., Ng, M.M., Ma, H.T., Hypopituitarism after tuberculous meningitis in childhood (1993) Ann Intern Med, 118, pp. 701-706
hcfmusp.relation.referenceLeger, J., Danner, S., Simon, D., Garel, C., Czernichow, P., Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood (2005) J Clin Endocrinol Metab, 90, pp. 650-656
hcfmusp.relation.referenceLongobardi, S., Merola, B., Pivonello, R., Di Rella, F., Di Somma, C., Colao, A., Ghigo, E., Lombardi, G., Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood (1996) J Clin Endocrinol Metab, 81, pp. 1244-1247
hcfmusp.relation.referenceMachinis, K., Pantel, J., Netchine, I., Leger, J., Camand, O.J., Sobrier, M.L., Dastot-Le Moal, F., Amselem, S., Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4 (2001) Am J Hum Genet, 69, pp. 961-968
hcfmusp.relation.referenceMaghnie, M., Ambrosini, L., Cappa, M., Pozzobon, G., Ghizzoni, L., Ubertini, M.G., Di Iorgi, N., Loche, S., Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies (2006) J Clin Endocrinol Metab, 91, pp. 2900-2905
hcfmusp.relation.referenceMaghnie, M., Ghirardello, S., Genovese, E., Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate (2004) J Endocrinol Invest, 27, pp. 496-509
hcfmusp.relation.referenceMaghnie, M., Strigazzi, C., Tinelli, C., Autelli, M., Cisternino, M., Loche, S., Severi, F., Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults (1999) J Clin Endocrinol Metab, 84, pp. 1324-1328
hcfmusp.relation.referenceMcnay, D.E., Turton, J.P., Kelberman, D., Woods, K.S., Brauner, R., Papadimitriou, A., Keller, E., Dattani, M.T., HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism (2007) J Clin Endocrinol Metab, 92, pp. 691-697
hcfmusp.relation.referenceMendonca, B.B., Osorio, M.G., Latronico, A.C., Estefan, V., Lo, L.S., Arnhold, I.J., Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene (1999) J Clin Endocrinol Metab, 84, pp. 942-945
hcfmusp.relation.referenceMitchell, L.A., Thomas, P.Q., Zacharin, M.R., Scheffer, I.E., Ectopic posterior pituitary lobe and periventricular heterotopia:cerebral malformations with the same underlying mechanism? (2002) AJNR, 23, pp. 1475-1481
hcfmusp.relation.referenceMiyamoto, J., Hasegawa, Y., Ohnami, N., Onigata, K., Kinoshita, E., Nishi, Y., Tachibana, K., Hasegawa, T., Development of growth hormone and adrenocorticotropic hormone deficiencies in patients with prenatal or perinatal-onset hypothalamic hypopituitarism having invisible or thin pituitary stalk on magnetic resonance imaging (2001) Endocr J, 48, pp. 355-362
hcfmusp.relation.referenceMoon, R.J., Wilson, P., Kirkham, F.J., Davies, J.H., Growth monitoring following traumatic brain injury (2009) Arch Dis Child, 94, pp. 699-701
hcfmusp.relation.referenceMorris, K.P., Coulthard, M.G., Smith, P.J., Craft, A.W., Renovascular and growth effects of childhood sarcoid (1996) Arch Dis Child, 75, pp. 74-75
hcfmusp.relation.referenceMuller, H.L., Recent advances in diagnosis, treatment and follow-up (2008) Horm Res, 69, pp. 193-202
hcfmusp.relation.referenceNash, J., Cheng, J.S., Meyer, G.A., Remler, B.F., Chiari type I malformation: overview of diagnosis and treatment (2002) WMJ, 101, pp. 35-40
hcfmusp.relation.referencePrice, D.A., Growth hormone therapy in pediatrics-20 years of KIGS (2007) Growth hormone treatment of children with previous craniopharyngioma: the KIGS experience, , Ranke MB, Price DA, Reiter EO, editors, Basel: Karger
hcfmusp.relation.referencePrice, D.A., Wilton, P., Jonssona, P., Albertsson-Wikland, K., Chatelain, P., Cutfield, W., Ranke, M.B., Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996 (1998) Horm Res, 49, pp. 91-97
hcfmusp.relation.referenceRanke, M.B., (1987) Acta Paediatr Scand Suppl, 331, pp. 80-82
hcfmusp.relation.referenceRanke, M.B., Lindberg, A., Albertsson-Wikland, K., Wilton, P., Price, D.A., Reiter, E.O., Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH deficiency: analysis of data from KIGS (2005) J Clin Endocrinol Metab, 90, pp. 1966-1971
hcfmusp.relation.referenceRanke, M.B., Lindberg, A., Chatelain, P., Wilton, P., Cutfield, W., Albertsson-Wikland, K., Price, D.A., Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study (1999) J Clin Endocrinol Metab, 84, pp. 1174-1183
hcfmusp.relation.referenceRanke, M.B., Price, D.A., Albertsson-Wikland, K., Maes, M., Lindberg, A., Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study (1997) Horm Res, 48, pp. 62-71
hcfmusp.relation.referenceRanke, M.B., Price, D.A., Reiter, E.O., (2007) Growth hormone therapy in pediatrics-20 years of KIGS, , Basel: Karger;
hcfmusp.relation.referenceRao, V.J., James, R.A., Mitra, D., Imaging characteristics of common suprasellar lesions with emphasis on MRI findings (2008) Clin Radiol, 63, pp. 939-947
hcfmusp.relation.referenceReiter, E.O., Price, D.A., Wilton, P., Albertsson-Wikland, K., Ranke, M.B., Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database (2006) J Clin Endocrinol Metab, 91, pp. 2047-2054
hcfmusp.relation.referenceReiter, E.O., Rosenfeld, R.G., Normal and aberrant growt (2002) Williams textbook of endocrinology, pp. 1003-1114. , Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors, 10th ed. Philadelphia, PA: WB Saunders
hcfmusp.relation.referenceRumboldt, Z., Pituitary adenomas (2005) Top Mag Reson Imaging, 16, pp. 277-288
hcfmusp.relation.referenceRupp, D., Molitch, M., Pituitary stalk lesions (2008) Curr Opin Endocrinol Diabetes Obes, 15, pp. 339-345
hcfmusp.relation.referenceSanford, R.A., Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery (1994) Pediatr Neurosurg, 21, pp. 39-43
hcfmusp.relation.referenceSavage, M.O., Chan, L.F., Grossman, A.B., Storr, H.L., Work-up and management of paediatric Cushing's syndrome (2008) Curr Opin Endocrinol Diabetes Obes, 15, pp. 346-351
hcfmusp.relation.referenceSchonau, E., Westermann, F., Rauch, F., Stabrey, A., Wassmer, G., Keller, E., Bramswig, J., Blum, W.F., A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency (2001) Eur J Endocrinol, 144, pp. 13-20
hcfmusp.relation.referenceShalet, S.M., Gibson, B., Swindell, R., Pearson, D., Effect of spinal irradiation on growth (1987) Arch Dis Child, 62, pp. 461-464
hcfmusp.relation.referenceTajima, T., Ohtake, A., Hoshino, M., Amemiya, S., Sasaki, N., Ishizu, K., Fujieda, K., OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary (2009) J Clin Endocrinol Metab, 94, pp. 314-319
hcfmusp.relation.referencevan der Werff ten Bosch, J.J., Bot, A., (1990) Clin Endocrinol (Oxf), 32, pp. 707-717
hcfmusp.relation.referenceWebb, E.A., Dattani, M.T., Septo-optic dysplasia (2009) Eur J Human Genet, p. 22. , epub ahead
hcfmusp.relation.referenceWit, J.M., Kamp, G.A., Rikken, B., Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature (1996) Pediatr Res, 39, pp. 295-302
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication2d7ecbc5-e278-4b88-950f-39267392ea1c
relation.isAuthorOfPublicationa8b0af8f-cf8d-4dcf-b2a6-63604abc6b5c
relation.isAuthorOfPublicationf9dd8bf5-173e-4843-93cd-66012ee0ef1b
relation.isAuthorOfPublication6d18feeb-c295-4974-af31-3bd95344395b
relation.isAuthorOfPublication7f059c63-5e5d-4bf9-94dc-5d159546a4a0
relation.isAuthorOfPublication354247b0-4a1e-4870-bbda-4da41a0fec0e
relation.isAuthorOfPublication42377b44-4755-45df-baa0-9d7f45a142e3
relation.isAuthorOfPublication.latestForDiscovery2d7ecbc5-e278-4b88-950f-39267392ea1c
Arquivos